To further assess this hypothesis, we suggest a long-term, prospective clinical study measuring NF-κB expression levels of CRC patient colonic specimens matched with long-term follow-up data regarding metastatic disease recurrence. The gene discussed is NFKB1; the disease is colorectal carcinoma.